tiprankstipranks
Lantern Pharma Discusses Q3 Financial Results Webinar
PremiumCompany AnnouncementsLantern Pharma Discusses Q3 Financial Results Webinar
3M ago
Lantern Pharma Advances AI-Driven Cancer Therapies
Premium
Company Announcements
Lantern Pharma Advances AI-Driven Cancer Therapies
3M ago
Lantern Pharma reports Q3 EPS (42c), one estimate (56c)
Premium
The Fly
Lantern Pharma reports Q3 EPS (42c), one estimate (56c)
3M ago
Lantern updates ongoing Phase 2 HARMONIC trial for ‘Never Smokers’
PremiumThe FlyLantern updates ongoing Phase 2 HARMONIC trial for ‘Never Smokers’
6M ago
Lantern progresses toward diagnostic for LP-184 for oncology clinical trials use
Premium
The Fly
Lantern progresses toward diagnostic for LP-184 for oncology clinical trials use
7M ago
Lantern receives certificate of patent from Japan Patent Office for LP-284
Premium
The Fly
Lantern receives certificate of patent from Japan Patent Office for LP-284
8M ago
Lantern Pharma’s Triple Threat: Inflation, Global Tensions, and Pandemic Impacts Jeopardize Financial Health
PremiumCompany AnnouncementsLantern Pharma’s Triple Threat: Inflation, Global Tensions, and Pandemic Impacts Jeopardize Financial Health
11M ago
Lantern Pharma Announces Fiscal Year and Q4 Results Webinar
Premium
Company Announcements
Lantern Pharma Announces Fiscal Year and Q4 Results Webinar
11M ago
Lantern Pharma reports Q4 EPS (39c), two estimates (40c)
Premium
The Fly
Lantern Pharma reports Q4 EPS (39c), two estimates (40c)
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100